You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ultra-central lung cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Early Stage NSCLC, NSCLC Trial in Saint Louis (Computed tomography-guided stereotactic adaptive radiotherapy, ETHOS)

Not yet recruiting
  • Early Stage Non-small Cell Lung Cancer
  • Non-small Cell Lung Cancer
  • Computed tomography-guided stereotactic adaptive radiotherapy
  • ETHOS
  • Saint Louis, Missouri
    Washington University School of Medicine
Mar 14, 2023

Non Small Cell Lung Cancer Trial in Canada (SBRT)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • SBRT
  • Vancouver, British Columbia, Canada
  • +6 more
Apr 12, 2022

Early Lung Cancer, Stereotactic Body Radiotherapy Trial in Peking (SBRT)

Not yet recruiting
  • Early Lung Cancer
  • Stereotactic Body Radiotherapy
  • SBRT
  • Peking, Beijing, China
    Department of radiation oncology, Peking University Third Hospit
Mar 26, 2023

SBRT in Reirradiation for Ultra-central Thoracic Malignant

Recruiting
  • Stereotactic Body Radiation Therapy
  • +3 more
  • stereotacitic body radiation therapy
  • Beijing, Beijing, China
    Peking University Third Hospital
May 31, 2022

Lung Cancer, Metastases to Lung, Radiotherapy Side Effect Trial in Denmark (STRICT LUNG, STAR LUNG)

Not yet recruiting
  • Lung Cancer
  • +2 more
  • STRICT LUNG
  • STAR LUNG
  • Aalborg, Denmark
  • +5 more
Apr 24, 2022

Non-small Cell Lung Cancer With Central Nervous System

Recruiting
  • Lung Cancer With Central Nervous System Metastasis
  • lung cancer with brain /leptomeningeal metastasis
  • Taipei, Taiwan
    National Taiwan University Hospital
Sep 4, 2023

Lung Cancer Trial in Groningen (18F-FDG, PET/CT imaging)

Recruiting
  • Lung Cancer
  • Groningen, Netherlands
    University Medical Center Groningen
Jul 14, 2022

NSCLC Trial in Chongqing (procedure, drug, radiation)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • bronchial artery interventional therapy
  • +3 more
  • Chongqing, Chongqing, China
    Daping Hospital, Third Military Medical University
May 27, 2023

Lung Cancer Trial in Houston (Simulated Online Adaptive Planning, Stereotactic MRI-guided adaptive radiotherapy-SMART)

Recruiting
  • Lung Cancer
  • Simulated Online Adaptive Planning
  • Stereotactic MRI-guided adaptive radiotherapy-SMART
  • Houston, Texas
    M. D. Anderson Cancer Center
Nov 17, 2022

Non Small Cell Lung Cancer Trial in Buffalo (SBRT)

Recruiting
  • Non Small Cell Lung Cancer
  • SBRT
  • Buffalo, New York
    Roswell Park Cancer Institute
Sep 27, 2022

Advanced Squamous Non-Small-Cell Lung Cancer Trial (Trilaciclib, Carboplatin, Paclitaxel)

Not yet recruiting
  • Advanced Squamous Non-Small-Cell Lung Cancer
  • (no location specified)
Jun 11, 2023

Lung Cancer, Lung Tumor Trial in Miami (Stereotactic Adaptive Ablative Radiotherapy at 50 Gy (Gray), Stereotactic Adaptive

Recruiting
  • Lung Cancer
  • Lung Tumor
  • Stereotactic Adaptive Ablative Radiotherapy at 50 Gy (Gray)
  • Stereotactic Adaptive Ablative Radiotherapy at 60 Gy (Gray)
  • Miami, Florida
    Miami Cancer Institute
May 24, 2022

Lung Cancer, Advanced Cancer, Caregiver Burden Trial in Changsha (Acceptance and Commitment Therapy (ACT) plus health education,

Not yet recruiting
  • Lung Cancer
  • +2 more
  • Acceptance and Commitment Therapy (ACT) plus health education
  • Health education
  • Changsha, Hunan, China
    Xiangya Hospital Central South University
May 23, 2023

Construction of Cavitary Central Lung Cancer

Not yet recruiting
  • Central Lung Cancer
    • (no location specified)
    Mar 3, 2022

    NSCLC Trial (Furmonertinib)

    Not yet recruiting
    • Non-Small Cell Lung Cancer
    • (no location specified)
    Aug 10, 2023

    Lung Cancer, Advanced Cancer Trial in Changsha (Acceptance and Commitment Therapy (ACT), Usual care)

    Completed
    • Lung Cancer
    • Advanced Cancer
    • Acceptance and Commitment Therapy (ACT)
    • Usual care
    • Changsha, Hunan, China
      Xiangya Hospital Central South University
    Oct 3, 2022

    Brain Metastases From NSCLC Trial (Stereotactic Radiation Therapy, Durvalumab)

    Not yet recruiting
    • Brain Metastases From Non-small Cell Lung Cancer
    • (no location specified)
    May 24, 2022

    NSCLC Trial in Guangzhou (TGRX-326)

    Recruiting
    • Non-small Cell Lung Cancer
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Jul 18, 2023

    Central Nervous System Metastatic EGFR Mutation Positive NSCLC

    Not yet recruiting
    • NSCLC
      • Changsha, Hunan, China
        Hunan Cancer hospital
      Aug 6, 2023

      Lung Cancer Screening Trial in Oulu, Vaasa (Smoking cessation mobile application, Written material for smoking cessation)

      Recruiting
      • Lung Cancer Screening
      • Smoking cessation mobile application
      • Written material for smoking cessation
      • Oulu, Finland
      • +1 more
      Nov 18, 2022

      Depression, Anxiety Trial in Xiangtan (MSC intervention)

      Completed
      • Depression, Anxiety
      • MSC intervention
      • Xiangtan, Hunan, China
        Xiangtan Central Hospital
      Dec 15, 2022

      Small Cell Lung Cancer, Immunotherapy Trial in Changsha (chronic psychological stress)

      Recruiting
      • Small Cell Lung Cancer
      • Immunotherapy
      • chronic psychological stress
      • Changsha, Hunan, China
        Department of Oncology, The Second Xiangya Hospital, Central Sou
      Jul 22, 2023

      Advanced Lung Cancer, Ovarian Cancer Trial in Changsha, Yangzhou, Shanghai (AL2846 capsule)

      Recruiting
      • Advanced Lung Cancer
      • Ovarian Cancer
      • AL2846 capsule
      • Changsha, Hunan, China
      • +3 more
      Apr 4, 2023

      Non-small-cell Lung Cancer Trial in China (TQB2450 +Anlotinib+Docetaxel, TQB2450 +Androtinib Placebo+Docetaxel)

      Recruiting
      • Non-small-cell Lung Cancer
      • TQB2450 +Anlotinib+Docetaxel
      • TQB2450 +Androtinib Placebo+Docetaxel
      • Huizhou, Guangdong, China
      • +4 more
      Nov 15, 2023

      NSCLC (NSCLC) Trial in Canada, Japan, United States (iSABR, 25 Gray in 1 fraction for small peripheral tumors, iSABR, 50 Gray in

      Completed
      • Non-small Cell Lung Cancer (NSCLC)
      • iSABR, 25 Gray in 1 fraction for small peripheral tumors
      • +5 more
      • Stanford, California
      • +3 more
      Jul 27, 2022